Eli Lilly (United States)

21.1k papers and 895.7k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (United States) have published 21.1k papers, which have received a total of 895.7k indexed citations. Scholars at this organization have produced 5.8k papers in Molecular Biology, 2.6k papers in Oncology and 2.3k papers in Endocrinology, Diabetes and Metabolism on the topics of Diabetes Treatment and Management (1.0k papers), Neuroscience and Neuropharmacology Research (929 papers) and Diabetes Management and Research (902 papers). Their work is cited by papers focused on Molecular Biology (269.1k citations), Physiology (108.9k citations) and Psychiatry and Mental health (103.5k citations). Authors at Eli Lilly (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Eli Lilly (United States)'s most productive authors include Steven Wrighton, Frank P. Bymaster, Kelly R. Bales, Darryle D. Schoepp and Steven M. Paul.

In The Last Decade

Fields of papers published by authors at Eli Lilly (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Eli Lilly (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Eli Lilly (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (United States) more than expected).

Rankless by CCL
2025